Video to Promote HPV Vaccination
Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination
1 other identifier
interventional
110
1 country
2
Brief Summary
The purpose of this research study is to determine if video-based education will increase HPV vaccination rates among 11 - 17 year olds.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2014
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 16, 2014
CompletedFirst Posted
Study publicly available on registry
July 22, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2018
CompletedJune 1, 2018
May 1, 2018
2.4 years
July 16, 2014
May 31, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
HPV Vaccination Series Initiation
Number of HPV vaccine doses received among study participants
90 days
HPV Vaccine Series Initiation
HPV Vaccine Receipt among study participants
0 days
Secondary Outcomes (2)
HPV Vaccine Series Initiation (depending on male versus female narrator)
0 days
HPV Vaccine Series Initiation (depending on male versus female narrator)
90 days
Other Outcomes (1)
HPV Vaccine Awareness
0 days
Study Arms (2)
Vaccine Information Statement
NO INTERVENTIONStudy participants will receive the HPV Vaccine Information Statement (VIS) which is part of routine care.
Video & Vaccine Information Statement
EXPERIMENTALParticipants will view an educational video about the HPV vaccine with a male or female narrator. Participants will also receive the HPV Vaccine Information Statement (VIS) which is part of routine care.
Interventions
Participants will watch an educational video about the quadrivalent HPV vaccine (Gardasil) narrated by either a male or female.
Eligibility Criteria
You may qualify if:
- Parent-child dyads in which the child is a male or female age 11 to 17 years who has not received the HPV vaccine
You may not qualify if:
- Parent-child dyads in which the child has received the HPV vaccine
- Parent-child dyads in which the child is older than 18 at the time of enrollment
- Non-English speakers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's Hospital of Philadelphialead
- Noble Medical, LLCcollaborator
Study Sites (2)
Primary Care, Flourtown, Children's Hospital of Philadelphia
Flourtown, Pennsylvania, 19031, United States
Nicholas and Athena Karabots Pediatric Care Center
Philadelphia, Pennsylvania, 19139, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristen A. Feemster, MD MPH MSHP
Children's Hospital of Philadephia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2014
First Posted
July 22, 2014
Study Start
July 1, 2014
Primary Completion
December 1, 2016
Study Completion
May 31, 2018
Last Updated
June 1, 2018
Record last verified: 2018-05